TARGETING CARBOHYDRATE METABOLISM IN LEISHMANIA

Grant number: 1100000 | Funding period: 2016 - 2019

Completed

Abstract

There is an urgent need to develop new drugs to treat human leishmaniasis, a disease that causes debilitating and life-threatening diseases in millions of people worldwide. This project will investigate whether it is possible to develop a new generation of drugs that target a novel metabolic pathway in these parasites that we have shown to be essential for virulence.

University of Melbourne Researchers